Search clinical trials for: Permittivity
Total 1 results
-
Zedsen LimitedImperial College Healthcare NHS TrustRecruitingBreast Cancer | Benign Breast DiseaseUnited Kingdom
Sponsors and Collaborators
- The Fred Hollows Foundation, Australia
- Hazelden Betty Ford Foundation
- Familien Hede Nielsens Fond
- Advanced Life Solutions
- Janssen (China) Research & Development Center
- Prof. Jacques SCHRENZEL
- Markham Stouffville Hospital
- Custom Pharmaceuticals Limited
- Nestlé Health Science Belgium
- Pedro Gamito
- Braunschweig Integrated Centre of Systems Biology (BRICS), Germany
- Universitatea de Medicina si Farmacie Iuliu Hatieganu
- JMI Laboratories
- Stannah Stairlifts
- UZ Leuven, campus Pellenberg (Belgium)
- Hospital Samaritano Paulista
- Physip S.A
- IN-JET APS
- Dr. Praveen B.H
- Fogarty International Center of the National Institute of Health
- View Full List
Medical Conditions
- Gullian Barre Syndrome
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Endocarditis Infective
- Epidemic Hemorrhagic Fever
- Childhood Langerhans Cell Histiocytosis
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Skull Base Neoplasms
- Tay-Sachs Disease Ganglioside
- Chlamydophila Infections
- Predictors of Atrial Fibrillation Recurrences
- Fetus or Neonate Affected by External Version Before Labor
- Painless Hysteroscopy
- Closure; Foramen Ovale
- Spine Surgeries
- Psoriasis, Arthritic
- Pulmonary Adenocarcinoma
- Fracture Dislocation of Cervical Spine
- Multisystem Proteinopathy
- Ewing's Family Tumors
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- View Full List
Drug Interventions
- Estradiol+Drospirenone
- EFV +TVA
- Cereport
- Redifferentiation with retinoid acid
- Adapalene Gel 0.3%
- Semapimod
- Glimepiride
- Palliative care group first-line scheme
- High dose pantoprazole infusion
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- Chemotherapeutic Agent
- Azelastine hydrochloride (BAYR9258)
- Adriamycin
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- Qingkailing injection 40 ml
- Vehicle
- Neihulizumab
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Esomeprazole 40mg before
- View Full List
CROs by country
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Belarus
- Contract Research Organizations in Burundi
- Contract Research Organizations in Chile
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Mexico
- Contract Research Organizations in Romania
- Contract Research Organizations in Slovakia
- Contract Research Organizations in Sweden
- Contract Research Organizations in Venezuela
- CRO list by country